Skip to content

Apnea during moderate to deep sedation using either remimazolam, dexmedetomidine, propofol infusion: a retrospective cohort study

Apnea during moderate to deep sedation using either remimazolam, dexmedetomidine, propofol infusion: a retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007492
Enrollment
700
Registered
2022-06-30
Start date
2022-03-21
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Chungnam National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. over 18 years old 2. ASA classification 1~3 3. Orthopedic surgery under spinal anesthesia or brachial plexus block 4. sedation performed during surgery through continuous infusion of one of the three drugs, dexmedetomidine, propol, and remimazolam

Exclusion criteria

Exclusion criteria: 1. Oxygen administration during sedation and continuous end-tidal CO2 not monitored or no information exists 2. Vital Recorder record does not exist

Design outcomes

Primary

MeasureTime frame
end-tidal CO2;SpO2

Secondary

MeasureTime frame
respiratory rate

Countries

Korea, Republic of

Contacts

Public ContactBoohwi Hong

Chungnam National University Hospital

koho0127@gmail.com+82-42-280-7840

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026